Lecanemab 18-Month Outcomes Show Half Transition to Maintenance
A retrospective single-center cohort study published in Alzheimer's Research & Therapy reports that approximately half of patients with early Alzheimer’s ...
Tag: lecanemab
Lecanemab shows favorable real-world safety in Korean registry study of 663 patients
A Korean registry study of 663 patients at 32 hospitals found lecanemab had favorable real-world safety, with ARIA in 16.1 ...
Synthetic Receptors Rewired to Sense Amyloid Beta and Release Therapeutics in the Lab
A head-to-head laboratory comparison found that SNIPR and synNotch receptors, but not TRUCKs, supported amyloid beta-dependent expression of therapeutic transgenes ...
Real-world lecanemab data show ARIA risks and limited cognitive evidence
A meta-analysis of 37 real-world lecanemab studies found ARIA in 15.1% of cases, with higher rates among APOE ε4 homozygotes ...
Inside China’s Lecanemab Experiment: What Families Really Think of the New Alzheimer’s Drug
A new qualitative study from West China Hospital reveals how family caregivers of Alzheimer's patients in China experience lecanemab treatment, ...
Real-World Data Show Lecanemab Is Mostly Safe but Flag a Stroke Signal
A combined real-world cohort and FAERS analysis finds lecanemab generally safe in Alzheimer's patients but flags a strong, unlabeled signal ...
Virtual Review Board Brings New Alzheimer’s Drugs to Community Neurologists Safely
A Sutter Health virtual review board allowed general neurologists to safely prescribe and monitor amyloid-targeting Alzheimer's therapies in community settings, ...
Anti-Amyloid Therapy Shows No Impact on Short-Term Waste Clearance in Alzheimer’s Disease
A recent preliminary study led by researchers at Osaka Metropolitan University, Japan, offers new insights into the complex pathophysiology of ...
